Adial Pharmaceuticals has recently obtained a new US patent (number 11,905,562) for their leading investigational drug, AD04, which targets the ...
Adial Pharmaceuticals Inc. has recently received a new U.S. patent, marking a significant milestone for the company. This patent greatly ...
On February 13, 2024, Adial Pharmaceuticals received exciting news as they were granted a brand-new U.S. patent. This patent marks ...
On January 18, 2024, Adial Pharmaceuticals made a significant announcement, appointing Tony Goodman as their new Chief Operating Officer. This ...
